Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: Possible role of nitric oxide

Behavioural Brain Research

Volumn 206, Issue 1, 2010, Pages 38-46

  Kumar, Puneet ^a   Kumar, Anil ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

3 Nitropropionic acid; Flavanoids; Huntington's disease; Mitochondria; Nitric oxide; Oxidative stress

Indexed keywords

3 NITROPROPIONIC ACID; ARGININE; AURANTIIN; HESPERIDIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; DRUG RESPONSE; HUNTINGTON DISEASE LIKE SYNDROME; LOW DRUG DOSE; MALE; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; BODY WEIGHT; CATALASE; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; ELECTRON TRANSPORT COMPLEX I; ELECTRON TRANSPORT COMPLEX II; ELECTRON TRANSPORT COMPLEX IV; FLAVANONES; HAND STRENGTH; HESPERIDIN; HUNTINGTON DISEASE; LIPID PEROXIDATION; MALE; MITOCHONDRIA; MOTOR ACTIVITY; NITRIC OXIDE; NITRITES; NITRO COMPOUNDS; PROPIONIC ACIDS; RATS; RATS, WISTAR; ROTAROD PERFORMANCE TEST; SUPEROXIDE DISMUTASE;

EID: 70350196372     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.08.028     Document Type: Article

References (64)

1. Middleton Jr. E., Kandaswami C., and Theoharides T.C. The effects of plant flavonoids on mammalian cells. Implications for inflammation, heart disease, and cancer. Pharmacol Rev 52 (2000) 673-751
2. Prior R.L., and Cao G. Analysis of botanicals and dietary supplements for antioxidant capacity: a review. J AOAC Int 83 (2000) 950-956
3. Renugadevi J., and Prabu S.M. Naringenin protects against cadmium-induced oxidative renal dysfunction in rats. Toxicology 256 (2009) 128-134
4. Chen Y.T., Zheng R.L., Jia Z.J., and Ju Y. Flavonoids as superoxide scavengers and antioxidants. Free Radic Biol Med 9 (1990) 19-21
5. Jagetia G.C., and Reddy T.K. Modulation of radiation-induced alteration in the antioxidant status of mice by naringin. Life Sci 77 (2005) 780-794
6. Schroeter H., Boyd C., Spencer J.P., Williams R.J., Cadenas E., and Rice-Evans C. MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide. Neurobiol Aging 23 (2002) 861-880
7. Cotelle N., Bernier J.L., Catteau J.P., Pommery J., Wallet J.C., and Gaydou E.M. Antioxidant properties of hydroxy-flavones. Free Radic Biol Med 20 (1996) 35-43
8. Kumar P., Kalonia H., and Kumar A. Sesamol attenuate 3-nitropropionic acid-induced Huntington-like behavioral, biochemical, and cellular alterations in rats. J Asian Nat Prod Res 11 (2009) 439-450
9. Lopez-Lopez G., Moreno L., Cogolludo A., Galisteo M., Ibarra M., Duarte J., et al. Nitric oxide (NO) scavenging and NO protecting effects of quercetin and their biological significance in vascular smooth muscle. Mol Pharmacol 65 (2004) 851-859
10. Raso G.M., Meli R., Di Carlo G., Pacilio M., and Di Carlo R. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1. Life Sci 68 (2001) 921-931
11. Ishige K., Schubert D., and Sagara Y. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic Biol Med 30 (2001) 433-446
12. Kumar P., Padi S.S., Naidu P.S., and Kumar A. Cyclooxygenase inhibition attenuates 3-nitropropionic acid-induced neurotoxicity in rats: possible antioxidant mechanisms. Fundam Clin Pharmacol 21 (2007) 297-306
13. Nakagawa T., and Yokozawa T. Direct scavenging of nitric oxide and superoxide by green tea. Food Chem Toxicol 40 (2002) 1745-1750
14. Haenen G.R., Paquay J.B., Korthouwer R.E., and Bast A. Peroxynitrite scavenging by flavonoids. Biochem Biophys Res Commun 236 (1997) 591-593
15. Heijnen C.G., Haenen G.R., van Acker F.A., van der Vijgh W.J., and Bast A. Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups. Toxicol In Vitro 15 (2001) 3-6
16. Lorenz P., Roychowdhury S., Engelmann M., Wolf G., and Horn T.F. Oxyresveratrol and resveratrol are potent antioxidants and free radical scavengers: effect on nitrosative and oxidative stress derived from microglial cells. Nitric Oxide 9 (2003) 64-76
17. Patocka J., Bielavsky J., Cabal J., and Fusek J. 3-Nitropropionic acid and similar nitrotoxins. Acta Medica (Hradec Kralove) 43 (2000) 9-13
18. Alexi T., Hughes P.E., Faull R.L., and Williams C.E. 3-Nitropropionic acid's lethal triplet: cooperative pathways of neurodegeneration. Neuroreport 9 (1998) R57-64
19. Kumar P., and Kumar A. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease. J Med Food 12 (2009) 591-600
20. Kumar P., and Kumar A. Effect of lycopene and epigallocatechin-3-gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: a novel nitric oxide mechanism. Food Chem Toxicol (2009)
21. Kumar P., and Kumar A. Neuroprotective effect of cyclosporine and FK506 against 3-nitropropionic acid induced cognitive dysfunction and glutathione redox in rat: possible role of nitric oxide. Neurosci Res 63 (2009) 302-314
22. Akula K.K., Dhir A., and Kulkarni S.K. Nitric oxide signaling pathway in the anti-convulsant effect of adenosine against pentylenetetrazol-induced seizure threshold in mice. Eur J Pharmacol 587 (2008) 129-134
23. Kaur G., Tirkey N., and Chopra K. Beneficial effect of hesperidin on lipopolysaccharide-induced hepatotoxicity. Toxicology 226 (2006) 152-160
24. Wills E.D. Mechanisms of lipid peroxide formation in animal tissues. Biochem J 99 (1966) 667-676
25. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., and Tannenbaum S.R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126 (1982) 131-138
26. Luck H. Catalase. In: Bergmeyer H.U. (Ed). Methods of enzymatic analysis (1971), Academic Press, New York 885-893
27. Kono Y. Generation of superoxide radical during auto-oxidation of hydroxylamine and an assay of superoxide dismutase. Arch Biochem Biophys 186 (1978) 189-195
28. Gornall A.G., Bardawill C.J., and David M.M. Determination of serum proteins by means of the biuret reaction. J Biol Chem 177 (1949) 751-766
29. Berman S.B., and Hastings T.G. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease. J Neurochem 73 (1999) 1127-1137
30. King T.E., and Howard R.L. Preparations and properties of soluble NADH dehydrogenases from cardiac muscle. Methods Enzymol 10 (1967) 275-284
31. King T.E. Preparation of succinate dehydrogenase and reconstitution of succinate oxidase. Methods Enzymol 10 (1967) 322-331
32. Sottocasa G.L., Kuylenstierna B., Ernster L., and Bergstrand A. An electron-transport system associated with the outer membrane of liver mitochondria. A biochemical and morphological study. J Cell Biol 32 (1967) 415-438
33. Liu Y., Peterson D.A., Kimura H., and Schubert D. Mechanisms of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolinium bromide (MTT) reduction. J Neurochem 69 (1997) 581-593
34. Brouillet E., Guyot M.C., Mittoux V., Altairac S., Conde F., Palfi S., et al. Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. J Neurochem 70 (1998) 794-805
35. Matthews R.T., Yang L., Jenkins B.G., Ferrante R.J., Rosen B.R., Kaddurah-Daouk R., et al. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease. J Neurosci 18 (1998) 156-163
36. Aldridge J.W., Berridge K.C., and Rosen A.R. Basal ganglia neural mechanisms of natural movement sequences. Can J Physiol Pharmacol 82 (2004) 732-739
37. Teunissen C.E., Steinbusch H.W., Angevaren M., Appels M., de Bruijn C., Prickaerts J., et al. Behavioural correlates of striatal glial fibrillary acidic protein in the 3-nitropropionic acid rat model: disturbed walking pattern and spatial orientation. Neuroscience 105 (2001) 153-167
38. Kumar P., and Kumar A. Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunctions in rat brain. Prog Neuropsychopharmacol Biol Psychiatry 33 (2009) 100-108
39. Hinton S.C., Paulsen J.S., Hoffmann R.G., Reynolds N.C., Zimbelman J.L., and Rao S.M. Motor timing variability increases in preclinical Huntington's disease patients as estimated onset of motor symptoms approaches. J Int Neuropsychol Soc 13 (2007) 539-543
40. Liu L., Xu D.M., and Cheng Y.Y. Distinct effects of naringenin and hesperetin on nitric oxide production from endothelial cells. J Agric Food Chem 56 (2008) 824-829
41. Timoshin A.A., Dorkina E.G., Paukova E.O., and Vanin A.F. Quercetin and hesperidin decrease the formation of nitric oxide radicals in rat liver and heart under the conditions of hepatosis. Biofizika 50 (2005) 1145-1149
42. Vafeiadou K., Vauzour D., Lee H.Y., Rodriguez-Mateos A., Williams R.J., and Spencer J.P. The citrus flavanone naringenin inhibits inflammatory signaling in glial cells and protects against neuroinflammatory injury. Arch Biochem Biophys 484 (2009) 100-109
43. Gaur V., Aggarwal A., and Kumar A. Protective effect of naringin against ischemic reperfusion cerebral injury: possible neurobehavioral, biochemical and cellular alterations in rat brain. Eur J Pharmacol 616 (2009) 147-154
44. Haller C., and Hizoh I. The cytotoxicity of iodinated radio contrast agents on renal cells in vitro. Invest Radiol 39 (2004) 149-154
45. Tunez I., Montilla P., Del Carmen Munoz M., Feijoo M., and Salcedo M. Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington's disease. J Pineal Res 37 (2004) 252-256
46. Perez-De La Cruz V., Elinos-Calderon D., Robledo-Arratia Y., Medina-Campos O.N., Pedraza-Chaverri J., Ali S.F., et al. Targeting oxidative/nitrergic stress ameliorates motor impairment, and attenuates synaptic mitochondrial dysfunction and lipid peroxidation in two models of Huntington's disease. Behav Brain Res 199 (2009) 210-217
47. Rajadurai M., and Prince P.S. Naringin ameliorates mitochondrial lipid peroxides, antioxidants and lipids in isoproterenol-induced myocardial infarction in Wistar rats. Phytother Res 23 (2009) 358-362
48. Kanno S., Shouji A., Asou K., and Ishikawa M. Effects of naringin on hydrogen peroxide-induced cytotoxicity and apoptosis in P388 cells. J Pharmacol Sci 92 (2003) 166-170
49. Shiratori K., Ohgami K., Ilieva I., Jin X.H., Yoshida K., Kase S., et al. The effects of naringin and naringenin on endotoxin-induced uveitis in rats. J Ocul Pharmacol Ther 21 (2005) 298-304
50. Kim J.Y., Jung K.J., Choi J.S., and Chung H.Y. Hesperetin: a potent antioxidant against peroxynitrite. Free Radic Res 38 (2004) 761-769
51. Rosenstock T.R., Carvalho A.C., Jurkiewicz A., Frussa-Filho R., and Smaili S.S. Mitochondrial calcium, oxidative stress and apoptosis in a neurodegenerative disease model induced by 3-nitropropionic acid. J Neurochem 88 (2004) 1220-1228
52. Beal M.F., Brouillet E., Jenkins B.G., Ferrante R.J., Kowall N.W., Miller J.M., et al. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13 (1993) 4181-4192
53. Maridonneau-Parini I., Braquet P., and Garay R.P. Heterogeneous effect of flavonoids on K + loss and lipid peroxidation induced by oxygen-free radicals in human red cells. Pharmacol Res Commun 18 (1986) 61-72
54. Pradeep K., Park S.H., and Ko K.C. Hesperidin a flavanoglycone protects against gamma-irradiation induced hepatocellular damage and oxidative stress in Sprague-Dawley rats. Eur J Pharmacol 587 (2008) 273-280
55. Tunon M.J., Garcia-Mediavilla M.V., Sanchez-Campos S., and Gonzalez-Gallego J. Potential of flavonoids as anti-inflammatory agents: modulation of pro-inflammatory gene expression and signal transduction pathways. Curr Drug Metab 10 (2009) 256-271
56. Choi E.J., and Ahn W.S. Neuroprotective effects of chronic hesperetin administration in mice. Arch Pharm Res 31 (2008) 1457-1462
57. Gandhi C., Upaganalawar A., and Balaraman R. Protection against in vivo focal myocardial ischemia/reperfusion injury-induced arrhythmias and apoptosis by hesperidin. Free Radic Res (2009) 1-11
58. El-Sayed el S.M., Abo-Salem O.M., Abd-Ellah M.F., and Abd-Alla G.M. Hesperidin, an antioxidant flavonoid, prevents acrylonitrile-induced oxidative stress in rat brain. J Biochem Mol Toxicol 22 (2008) 268-273
59. Spencer J.P. The interactions of flavonoids within neuronal signaling pathways. Genes Nutr 2 (2007) 257-273
60. Olszanecki R., Gebska A., Kozlovski V.I., and Gryglewski R.J. Flavonoids and nitric oxide synthase. J Physiol Pharmacol 53 (2002) 571-584
61. Liang Y.C., Tsai S.H., Tsai D.C., Lin-Shiau S.Y., and Lin J.K. Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferators-activated receptor-gamma by flavonoids in mouse macrophages. FEBS Lett 496 (2001) 12-18
62. Brandi M.L. Flavonoids: biochemical effects and therapeutic applications. Bone Miner 19 (1992) S3-14
63. Galati E.M., Monforte M.T., Kirjavainen S., Forestieri A.M., Trovato A., and Tripodo M.M. Biological effects of hesperidin, a citrus flavonoid (note I): antiinflammatory and analgesic activity. Farmaco 40 (1994) 709-712
64. Guerra J.A., Molina M.F., Abad M.J., Villar A.M., and Paulina B. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids isolated from Tanacetum microphyllum. Int Immunopharmacol 6 (2006) 1723-1728